Company Data
MeiraGTx Holdings plc
Ticker
MGTX
Current Price
$5.12 -4.48%
Market Cap
$411.5M
Price Target
Refer to Report
Volume
555.2K
52wk Range
$3.85 - $8.75
Overview
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company’s pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and European Union.